GHK-Cu
peptide · headline503A compoundedChelates copper ions to form a biologically active GHK-Cu complex
Overview
GHK-Cu is a naturally occurring copper-binding tripeptide known for its regenerative and anti-aging effects. It promotes collagen production, speeds wound healing, improves skin texture, and supports hair follicle health. Widely used in cosmetic serums and creams for skin rejuvenation and hair growth in vitro and in vivo.
How it works
- Chelates copper ions to form a biologically active GHK-Cu complex
- Upregulates genes involved in wound healing, skin remodeling, and antioxidant defense
- Suppresses expression of inflammatory cytokines and proteases (e.g., MMPs)
- Increases fibroblast proliferation and migration in injured tissues
Dosing
Apply 1% topical solution once or twice daily to skin or scalp for 4–12 weeks. Maintenance use is safe long-term.
Caution: In research, topical concentrations range from 0.1% to 1%, while injectable animal studies use 1–5 mg/kg. No dosing has been approved for therapeutic use.
Cycling
- Apply 1–2x daily for 8–12 weeks. Safe for continuous use as part of cosmetic maintenance protocols.
Side effects
- Common
- Mild redness and irritation (5–10% of new users, topical)
- Tingling or slight burning, temporary "purging" pimples
- Warnings
- Copper toxicity risk if injected incorrectly (abdominal pain, vomiting, tremors, metallic taste)
Stacking & combinations
- With
Follistatin 344
- Benefit
Synergistic dermal repair and anti-inflammatory response with BPC-157
- With
Snap-8
- Benefit
Enhances wrinkle-reducing effects when used with SNAP-8
Lifestyle support
- Diet
Adequate protein for collagen synthesis. Sufficient copper, zinc, and vitamin C.
- Sleep
Quality sleep. Appropriate skincare and wound-care protocols.
- Timing
Topical: daily application. Injectable: consistent daily SubQ.
- Exercise
Moderate activity as tolerated.
Research studies
Studies summarized for educational purposes only. Inclusion does not imply human use; referenced research was conducted in vitro, in animal models, or in regulated clinical trials.
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart L, Vasquez-Soltero JM, Margolina A. Biomed Res Int. 2015;2015:648108. View source ↗
This review synthesizes the molecular biology of GHK and the GHK-Cu complex across multiple cellular systems relevant to dermal research. The authors describe GHK-Cu's role in modulating expression of genes involved in extracellular matrix remodeling — including collagen, elastin, and glycosaminoglycan synthesis — and its activation of fibroblast and endothelial cell proliferation in vitro. Reported effects on antioxidant defense include induction of metallothioneins and modulation of oxidative stress markers. The review summarizes preclinical evidence for GHK-Cu's effects on tissue remodeling, hair follicle biology, and DNA damage repair pathways in cultured cells and animal models.
Researchers reviewed everything known at the time about how GHK-Cu affects skin cells. In lab studies, the peptide-copper complex appears to switch on genes that build the structural proteins skin needs — collagen, elastin, and the gels that hold them together. It also wakes up the cells that produce these proteins and helps blood vessels grow into healing tissue. Animal studies show it speeds up wound closure and reduces signs of cellular oxidative damage.
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. View source ↗
Using gene-expression datasets from the Broad Institute's Connectivity Map, the authors analyzed GHK's effect on the transcriptome of human cells. GHK exposure was associated with statistically significant modulation of more than 4,000 genes, with effects clustering around DNA repair pathways, ubiquitin-proteasome regulation, antioxidant defense, and inflammatory signaling. The authors propose that GHK-Cu's broad observed effects in preclinical models reflect this transcriptome-wide signaling rather than action on a single receptor.
Scientists used a large public database of gene activity to look at how GHK changes which genes are turned on or off in human cells. They found GHK affects thousands of genes — particularly ones involved in fixing DNA, recycling damaged proteins, calming inflammation, and protecting against oxidative damage. This suggests GHK doesn't have just one job: it acts like a master switch that adjusts many cellular maintenance programs at once.
Verified citations
3 · PubMed-checked- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.reviewPMID 26236730 ↗
- The tri-peptide GHK-Cu complex ameliorates LPS-induced acute lung injury in mice.mechanismPMID 27517151 ↗
- Tripeptide-copper complex GHK-Cu(II) improved healing in a rat model of ACL reconstruction.preclinicalPMID 25731775 ↗
Reconstitution calculator
Subcutaneous (SQ)= 0.3 mL on a U-100 insulin syringe
Assumes a U-100 insulin syringe (100 units = 1 mL). This is a preparation aid, not a protocol — dose and route are the prescriber's decision. store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days
Chemistry & PK
- Sequence
- Gly-His-Lys
- Half Life
- Not clearly established; local activity persists longer than plasma half-life
- Degradation
- Broken down by tissue peptidases and metal ion dissociation
- Molecular Weight
- 340.9
- Molecular Formula
- C14H24N6O4
- Tissue Specificity
- Affects skin, scalp, connective tissue, and epithelial layers
Bioavailability
- Oral
- Limited systemic activity; poorly absorbed orally
- Subq
- Rarely used via injection; topical route is preferred
Storage & handling
- Lyophilized
store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days
Legal / compounding
- EU
- Not Approved
- FDA
- Not Approved
- Canada
- Not Approved
- Australia
- Not Approved
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.